| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate |
1999-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d442331e5088bb56434070df0536a945
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0768b51e88570b28e9d13c7cbc97a45b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60f3ba6004c68f7a7224ad6164dadca3 |
| publicationDate |
2001-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
HU-9901830-A2 |
| titleOfInvention |
Nefazodone dosage forms |
| abstract |
The present invention relates to sustained release nefazodone formulations containing nefazodone hydrochloride, ionic and non-ionic gelling polymers, insoluble hydrophilic agents and optionally pharmaceutically acceptable excipients, which allow pH-dependent (pH-modulated) release of anefazodone. The compositions of the present invention may be formulated in unit dosage forms for improved oral administration. The dosage forms of the present invention are improved compared to prior art formulations in that they provide sustained release of the active ingredient with a similar concentration of immediate release dosage form and do not depend on gastrointestinal nutrition for release. SHE |
| priorityDate |
1998-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |